Multiple myeloma doesn’t typically cause headaches as a direct, primary symptom, but it can trigger them through several secondary pathways. Thickened blood, high calcium levels, anemia, kidney problems, and even the medications used to treat myeloma can all produce headaches. Understanding which mechanism is behind the headache matters, because some of these causes are medical emergencies while others are manageable side effects.
Thickened Blood and Poor Brain Circulation
Myeloma cells produce large quantities of abnormal proteins that accumulate in the bloodstream. When those protein levels climb high enough, blood becomes physically thicker and flows more sluggishly through small vessels. This condition, called hyperviscosity syndrome, is one of the most direct ways myeloma can cause headaches.
Normal blood has a relative viscosity of up to 1.6 compared to water. Symptoms of hyperviscosity rarely appear until that number exceeds about 4.0, but once it does, the brain doesn’t get adequate blood flow. Headache is one of the most common results, often accompanied by dizziness, blurred vision, confusion, or vertigo. In severe cases, hyperviscosity can mimic a stroke, causing weakness on one side of the body or slurred speech. The American Cancer Society lists these stroke-like symptoms as a medical emergency requiring immediate care.
High Calcium Levels
Myeloma breaks down bone tissue, releasing calcium into the blood. This is called hypercalcemia, and it affects a significant portion of myeloma patients. Calcium levels are classified by severity: mild (10.5 to 11.9 mg/dL), moderate (12.0 to 13.9 mg/dL), and crisis-level (14.0 to 16.0 mg/dL). As levels rise, neurological symptoms become more likely.
Mild hypercalcemia might cause fatigue or subtle mental fogginess. At moderate to severe levels, headaches, confusion, muscle weakness, and altered mental status can develop. These symptoms sometimes appear before a person even knows they have myeloma, making an unexplained headache paired with confusion or extreme fatigue worth investigating.
Anemia From Crowded Bone Marrow
Myeloma cells multiply inside bone marrow, gradually crowding out the normal cells that produce red blood cells. The result is anemia, which the Mayo Clinic lists among the most common complications of the disease. When red blood cell counts drop, your body delivers less oxygen to the brain and other tissues. This oxygen deficit commonly produces headaches along with fatigue, weakness, dizziness, and shortness of breath.
Anemia-related headaches tend to be dull and persistent rather than sharp or sudden. They often worsen with physical activity, since exertion increases the brain’s demand for oxygen that the blood can’t fully supply. These headaches typically improve as anemia is treated, whether through transfusions or medications that boost red blood cell production.
Kidney Dysfunction and Toxin Buildup
The abnormal proteins produced by myeloma cells can damage the kidneys, particularly the tiny tubules responsible for filtering waste. As kidney function declines, waste products that would normally be excreted accumulate in the blood. This buildup, known as uremia, is a well-known cause of headache. Uremic headaches are often described as a generalized, constant pressure that worsens over time as kidney function deteriorates.
Skull Lesions and Plasmacytomas
Myeloma can form localized tumors called plasmacytomas, and it can also create lytic lesions (holes in bone). When either of these occurs in the skull, headaches are a direct and expected symptom. Cleveland Clinic notes that skull-based plasmacytomas can cause headaches along with dizziness and vision problems. Extramedullary plasmacytomas, which grow in soft tissue outside the bone marrow, also list headache among their symptoms.
Myeloma patients more broadly can develop neurological complications from bone involvement at the base of the skull, compression fractures in the cervical spine, or cranial nerve compression. These structural problems tend to produce localized head or neck pain rather than the diffuse headache seen with metabolic causes like hypercalcemia or anemia.
Treatment-Related Headaches
Sometimes the headache isn’t from the disease itself but from the drugs used to fight it. Bortezomib, one of the most commonly prescribed myeloma treatments, causes headaches in roughly 26% of patients. It’s listed among the drug’s most frequent side effects alongside fatigue, nausea, and nerve pain. Dizziness occurs in about 14% of patients taking bortezomib as well, compounding the discomfort.
If headaches begin or worsen shortly after starting a new treatment regimen, the medication is a likely contributor. This is worth discussing with your care team, since adjusting the dose or switching therapies can sometimes resolve the problem without compromising treatment effectiveness.
How to Tell What’s Causing the Headache
The pattern and timing of the headache offers useful clues. A headache that develops gradually alongside increasing fatigue and shortness of breath points toward anemia. One that comes with bone pain, excessive thirst, and frequent urination suggests high calcium. Headaches paired with blurred vision, nosebleeds, or a feeling of mental “fog” may signal hyperviscosity.
Certain combinations demand urgent attention. Confusion, slurred speech, weakness on one side of the body, or sudden severe headache with vision changes can indicate that hyperviscosity is restricting blood flow to the brain. These symptoms overlap with stroke and require emergency evaluation. A sudden, severe headache in someone with known myeloma should never be dismissed as routine.
For myeloma patients experiencing new or worsening headaches, a blood panel checking calcium levels, kidney function, hemoglobin, and serum viscosity can usually identify the underlying cause quickly. Each of these triggers has a different treatment path, so pinpointing the mechanism is the first step toward relief.